Freenome, Inc. (FRNM) Put/Call Volume History

Put/call volume ratio compares the number of put options traded to call options traded. Extreme readings can signal shifts in market sentiment relative to recent norms.

Freenome, Inc. (FRNM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $120.6M, listed on NASDAQ, employing roughly 378 people, carrying a beta of 0.35 to the broader market. Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. Led by Aaron Elliott, public since 2026-07-21.

Put/call volume history tracks trading activity and sentiment over time. No recent options activity for FRNM as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options volume is reported and how to read the data →